The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical and Experimental Immunology

• Publication date

  2009-01-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1111/j.1365-2249.2008.03777.xPMID 19076832PMCID PMC2665683
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells

  2006cited by this paper
• Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.

  2006cited by this paper
• An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system.

  2005cited by this paper
• *N-Terminal Pro-BNP Levels in Patients with Congestive Heart Failure and Implantable Cardioverter-Defibrillator or Biventricular Pacemaker-Defibrillator Therapies.

  2005cited by this paper
• Local and systemic activity of the polysaccharide chitosan at lymphoid tissues after oral administration

  2005cited by this paper
• Modulation of surgical fibrosis by microbial zwitterionic polysaccharides.

  2005cited by this paper
• Oral tolerance

  2005cited by this paper
• Intestinal epithelial barrier and mucosal immunity

  2005cited by this paper
• Effective nasal influenza vaccine delivery using chitosan.

  2005cited by this paper
• Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen

  2004cited by this paper
• Dietary supplements for body-weight reduction: a systematic review.

  2004cited by this paper
• IL‐10‐Producing T Regulatory Type 1 Cells and Oral Tolerance

  2004cited by this paper
• Early events associated to the oral co-administration of type II collagen and chitosan: induction of anti-inflammatory cytokines.

  2004cited by this paper
• Chitosan induces different L-arginine metabolic pathways in resting and inflammatory macrophages.

  2003cited by this paper
• Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats

  2003cited by this paper
• Dendritic cells in immunity and tolerance-do they display opposite functions?

  2003cited by this paper
• CC Chemokine Ligand 2 and Its Receptor Regulate Mucosal Production of IL-12 and TGF-β in High Dose Oral Tolerance 1

  2003cited by this paper
• Mucosal immunity.

  2003cited by this paper
• Oral administration of proteoglycan isolated from Phellinus linteus in the prevention and treatment of collagen-induced arthritis in mice.

  2003cited by this paper
• Evolving concepts of rheumatoid arthritis

  2003cited by this paper
• Oral tolerance

  2003cited by this paper
• Orally Tolerized T Cells Are Only Able to Enter B Cell Follicles Following Challenge with Antigen in Adjuvant, but They Remain Unable to Provide B Cell Help1

  2002cited by this paper
• Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance.

  2002cited by this paper
• Detection of Early Changes in Autoimmune T Cell Phenotype and Function Following Intravenous Administration of Type II Collagen in a TCR-Transgenic Model1

  2002cited by this paper
• Kinetics and mode of peptide delivery via the respiratory mucosa determine the outcome of activation versus TH2 immunity in allergic inflammation of the airways.

  2002cited by this paper
• Pathogenesis of arthritis: recent research progress

  2001cited by this paper
• Unique Functions of CD11b+, CD8α+, and Double-Negative Peyer’s Patch Dendritic Cells1

  2001cited by this paper
• IL-12 and Th1 immune responses in human Peyer's patches.

  2001cited by this paper
• Chitosan: some pharmaceutical and biological aspects ‐ an update

  2001cited by this paper
• Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells.

  2001cited by this paper
• Sensitization and tolerance

  2001cited by this paper
• Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells.

  2001cited by this paper
• The Role of Dendritic Cells, B Cells, and M Cells in Gut-Oriented Immune Responses

  2001cited by this paper
• Can we induce tolerance in rheumatoid arthritis?

  2001cited by this paper
• The mucosal milieu creates tolerogenic dendritic cells and TR1 and TH3 regulatory cells

  2001cited by this paper
• Chitosan as a novel nasal delivery system for vaccines.

  2001cited by this paper
• Treatment of rheumatoid arthritis by oral administration of bovine tracheal type II collagen

  2001cited by this paper
• Oral toleragens in rheumatoid arthritis.

  2000cited by this paper
• Chitosan‐induced phospholipase A2 activation and arachidonic acid mobilization in P388D1 macrophages

  2000cited by this paper
• Induction of oral tolerance in the primed immune system: influence of antigen persistence and adjuvant form.

  2000cited by this paper
• Oral tolerance, an active immunologic process mediated by multiple mechanisms.

  2000cited by this paper
• Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.

  2000cited by this paper
• Prevention of collagen-induced arthritis in DBA/1 mice by oral administration of AZ-9, a bacterial polysaccharide from Klebsiella oxytoca.

  2000cited by this paper
• Modulation by cytokines of induction of oral tolerance to type II collagen.

  1999cited by this paper
• Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis

  1999cited by this paper
• Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen.

  1998cited by this paper
• Immune responses to dietary antigens: oral tolerance.

  1998cited by this paper
• Expanding dendritic cells in vivo enhances the induction of oral tolerance.

  1998cited by this paper
• Dendritic cells

  1998cited by this paper
• Oral collagen in the treatment of rheumatoid arthritis.

  1998cited by this paper
• Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial.

  1998cited by this paper
• A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

  1997cited by this paper
• Collagen and its interactions with chitosan, III some biological and mechanical properties.

  1996cited by this paper
• Anti-purified protein derivative cell-enzyme-linked immunosorbent assay, a sensitive method for early diagnosis of tuberculous meningitis

  1995cited by this paper
• Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen.

  1995cited by this paper
• Chitosan as a Novel Nasal Delivery System for Peptide Drugs

  1994cited by this paper
• A cell surface ELISA for the screening of monoclonal antibodies to antigens on viable cells in suspension.

  1994cited by this paper
• Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.

  1994cited by this paper
• Depressed cutaneous cell-mediated immunity in early rheumatoid arthritis.

  1990cited by this paper
• Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity.

  1988cited by this paper
• Enterically induced regulation of systemic immune responses. I. Lymphoproliferative responses in mice suppressed by ingested antigen.

  1983cited by this paper
• Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates

  1981cited by this paper
• Autoimmunity to type II collagen an experimental model of arthritis

  1977cited by this paper

• Exploration of chitosan and its modified derivatives as vaccine adjuvant: A Review

  2024cites this paper
• Role of chitosan in intestinal integrity: TLR4 and IFNAR signaling in the induction of E-cadherin and CD103 in mice.

  2024cites this paper
• Reviewing the biological activity of chitosan in the mucosa: Focus on intestinal immunity.

  2021cites this paper
• Collagen II-primed Foxp3 Transduced T Cells Ameliorate Collagen-induced Arthritis in Rats: The Effect of Antigenic Priming on T Regulatory Cell Function.

  2018cites this paper
• Characteristics of the Main Constituents Used in Bone Tissue Engineering

  2018cites this paper
• The Possible Protective Role of Powder Cuttlefish Bone, Crabshell and Eggshell on Osteoporotic Rats

  2018cites this paper
• 4.24 Biomaterials in Vaccine and Immunotherapy

  2017cites this paper
• Nanoparticulate Drug Delivery to Colorectal Cancer: Formulation Strategies and Surface Engineering.

  2016cites this paper
• Respuesta inmunológica e interacción microbiana en glándula mamaria bovina (Bos taurus): efecto del polisacárido quitosano

  2016cites this paper
• Chitin, a key factor in immune regulation: lesson from infection with fungi and chitin bearing parasites

  2015cites this paper
• Biomedical Biopolymers, their Origin and Evolution in Biomedical Sciences: A Systematic Review.

  2015cites this paper
• Award Number: W81XWH-10-1-0245 TITLE: Sustained Release Oral Nanoformulated Green Tea for Prostate Cancer Prevention PRINCIPAL INVESTIGATOR: Hasan Mukhtar, Ph.D. CONTRACTING ORGANIZATION: University of Wisconsin System Board of Regents

  2013cites this paper
• Biological and Pharmacological Activity of Chitosan and Derivatives

  2012cites this paper
• Chitosan drives anti-inflammatory macrophage polarisation and pro-inflammatory dendritic cell stimulation.

  2012cites this paper
• Chitosan enhances transcellular permeability in human and rat intestine epithelium.

  2012cites this paper
• Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.

  2012cites this paper
• Biomedical Applications of Chitosan: An Overview

  2012cites this paper
• Interleukin‐2/anti‐interleukin‐2 monoclonal antibody immune complex suppresses collagen‐induced arthritis in mice by fortifying interleukin‐2/STAT5 signalling pathways

  2012cites this paper
• Sustained Release Oral Nanoformulated Green Tea for Prostate Cancer

  2011cites this paper
• Chitosan Composites for Bone Tissue Engineering—An Overview

  2010cites this paper
• Signals elicited at the intestinal epithelium upon chitosan feeding contribute to immunomodulatory activity and biocompatibility of the polysaccharide.

  2010cites this paper
• Application of biomimetic mineralization: a prophylactic therapy for cracked teeth?

  2009cites this paper
• Ability of the polysaccharide chitosan to inhibit proliferation of CD4+ lymphocytes from mucosal inductive sites, in vitro and in vivo

  2009cites this paper